C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
11/2006
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1861606A Preparation process of 6'-nitroindolyline benzspriothiane
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135484 Azabicyclic compounds are central nervous system active agents
11/14/2006	US7135470 Thienopyridazines as IKK inhibitors
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/14/2006	CA2100812C Substituted aminothienopyridines, a process for their preparation and their use as medicaments
11/09/2006	WO2006118749A1 Thia-tetraazaacenaphthylene kinase inhibitors
11/09/2006	WO2006118320A1 Thienopyrimidone compound
11/09/2006	WO2006117304A1 Tetracyclic azapyrazinoindolines as 5-ht2 ligands
11/09/2006	WO2006087729B1 Rapid resolution process for clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph - form i
11/09/2006	US20060252752 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects
11/09/2006	US20060252751 specific compound N-(2-{[(3R)-1-(4-hydroxy-4-pyrimidin-4-ylcyclohexyl)pyrrolidin-3-yl]amino}-2-oxoethyl)-3-(trifluoromethyl)benzamide; multiple sclerosis; CCR2 and/or CCR5 antagonists
11/09/2006	US20060252093 Heterocyclic organic molecules through intramolecular formation of n-acyliminium ions
11/08/2006	EP1718654A1 Resolution of racemates of methyl alpha-5- 4,5,6,7-tetrahydr o 3,2-c thienopyridyl -(2-chlorophenil)acetate
11/08/2006	CN1860117A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/08/2006	CN1283610C Ketone compounds and compositions for cholesterol management and related uses
11/07/2006	US7132442 6H-thieno[2, 3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH)
11/07/2006	US7132295 Isotopically coded affinity markers 3
11/02/2006	WO2006116764A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
11/02/2006	WO2006116713A1 Substituted amide derivatives as protein kinase inhibitors
11/02/2006	WO2006114272A1 FURAN COMPOUNDS USEFUL AS EPl RECEPTOR ANTAGONISTS
11/02/2006	US20060247283 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides
11/02/2006	US20060247269 Thienopyridone derivatives as kinase inhibitors
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247243 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
11/02/2006	US20060247217 Tricyclic protein kinase inhibitors
11/02/2006	EP1716155A1 Substituted thieno¬2,3-d\|pyrimidines as inhibitors of tie2
11/02/2006	EP1716154A1 Process for the preparation of olanzapine form 1 useful as antipsychotic drug
11/02/2006	EP0885883B1 Fused heterocyclic compounds and pharmaceutical applications thereof
11/02/2006	DE102005019201A1 Neue Verbindungen zur Behandlung von entzündlichen Erkrankungen Novel compounds for the treatment of inflammatory diseases
11/02/2006	CA2599419A1 Dipeptidyl peptidase-iv inhibitors
11/01/2006	CN1856498A Thienopyridine and furopyridine kinase inhibitors
11/01/2006	CN1856490A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
10/2006
10/31/2006	US7129249 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
10/31/2006	CA2265712C Intermediates and process for preparing olanzapine
10/31/2006	CA2262796C 4-substituted beta-carbolines as immunomodulators
10/31/2006	CA2198177C High-molecular-weight polypropylene having a broad molecular-weight distribution
10/26/2006	WO2006113875A2 2 - pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain
10/26/2006	WO2006111549A1 Dihydrothienopyrimidines for the treatment of inflammatory diseases
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006	WO2006075255A3 Anti-inflamatory macrolide conjugates
10/26/2006	WO2006036941A3 Specific kinase inhibitors
10/26/2006	US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation
10/26/2006	US20060241106 Isoxazole compounds as inhibitors of heat shock proteins
10/26/2006	US20060241099 Use of 2-thia-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
10/26/2006	US20060240197 1,2-Dithienylcyclopentene derivatives reversibly interconvertible between different isomeric forms under suitable photochromic or electrochromic conditions; ultra-high density homopolymers prepared using ring-opening methathesis polymerization; high-density optical information storage systems; inks
10/26/2006	DE112004001116T5 Chinonverbindung und elektrophotographischer Photorezeptor und diese verwendendes elektrophotographisches Gerät Quinone compound and electrophotographic photoreceptor-use and this electrophotographic apparatus
10/26/2006	CA2605161A1 Dihydrothienopyrimidines for the treatment of inflammatory diseases
10/26/2006	CA2605075A1 2 - pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain
10/25/2006	EP1713812A1 New crystalline forms of clopidogrel hydrobromide and methods of their preparation
10/25/2006	EP1713789A1 2-halofuryl/thienyl-3-carboxamides
10/25/2006	EP1567501B1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
10/25/2006	CN1852748A Azepine derivatives as pharmaceutical agents
10/25/2006	CN1852712A Dual NK1/NK3 antagonists for treating schizophrenia
10/25/2006	CN1850827A Method for preparing (+)-(s-)-clopiclogrel hydrogensulfate (I)
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006	US7125989 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene
10/24/2006	US7125907 Thiolactones
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	CA2259031C Androgen receptor modulator compounds and methods
10/19/2006	WO2006110654A1 Spiroheterocyclic compounds and their uses as therapeutic agents
10/19/2006	WO2006109190A1 Tetracyclic monoamine reuptake inhibitors for treatment of cns diseases and disorders
10/19/2006	WO2006108636A1 Manufacture of thiolactones
10/19/2006	US20060235067 Such as: {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone relataed prostate cancer and pre-menopausal breast cancer
10/19/2006	US20060235010 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives
10/19/2006	US20060234314 Selective binding and analysis of macromolecules
10/19/2006	CA2604010A1 Spiroheterocyclic compounds and their uses as therapeutic agents
10/18/2006	EP1711825A2 Conjugated small molecules
10/18/2006	EP1711503A1 Synthesis of olanzapine and intermediates thereof
10/18/2006	EP1711495A2 Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer
10/18/2006	EP1711177A1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS
10/18/2006	CN1849323A Thienopyrroles as antiviral agents
10/18/2006	CN1849322A Thienopyrazoles
10/18/2006	CN1280300C Heterocyclic metallocene compounds and use thereof in catalyst systems for producing olefin polymers
10/18/2006	CN1280291C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/18/2006	CN1280275C Pyridione derivatives for tretment of atherosclerosis
10/18/2006	CN1279915C Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2, 3-D)-pyrimidine for treating of urinary incontinence
10/18/2006	CN1279906C Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof
10/17/2006	US7122679 Multicyclic compounds and the use thereof
10/17/2006	US7122572 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation
10/17/2006	US7122567 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
10/17/2006	US7122173 A compound having slowly-deactivating A-type K+ channel opening activity such as N-(5,5-dioxido-10-oxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide
10/17/2006	CA2238817C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
10/12/2006	WO2006107561A1 Tetrahydrothiopyrano pyrazole cannabinoid modulators
10/12/2006	WO2006106326A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
10/12/2006	WO2005118592A8 Tetrahydropyridothiophenes for use in the treatment of cancer
10/12/2006	US20060229306 4-(4-Ethylpiperazin-1-yl)-5-methyl-2-phenylthieno[2,3-d]pyrimidine-6-carbonitrile; asthma, atopic dermatitis, chronic obstructive pulmonary disease, Crohn's disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseases
10/12/2006	CA2603104A1 Tetrahydrothiopyrano pyrazole cannabinoid modulators
10/12/2006	CA2601983A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
10/11/2006	EP1709053A1 Stable salts of olanzapine
10/11/2006	EP1709035A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
10/11/2006	CN1845927A Microcrystal and medicinal preparation containing the same
10/11/2006	CN1845926A Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
10/10/2006	US7119205 Thienopyridones as AMPK activators for the treatment of diabetes and obesity
10/10/2006	US7119196 Anxiolytic agents with reduced sedative and ataxic effects
10/10/2006	US7119102 3-amino-6-{4-[2-hydroxy-2-(substituted heteroaryl)ethylamino]-piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxylic acid amides; reductive amination; I kappa B kinase inhibitors; autoimmune diseases; antiinflammatory and anticarcinogenic agents
10/10/2006	US7119099 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives
10/10/2006	CA2481848C Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation

1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 214